Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.9000 (1.8%) ($7.7600 - $7.9700) on Thu. Mar. 28, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.27% (three month average) | RSI | 50 | Latest Price | $7.9000(1.8%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | BCRX declines -3.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLC(4%) TBT(3%) BLOK(2%) IBB(2%) KWEB(2%) | Factors Impacting BCRX price | BCRX will decline at least -1.635% in a week (0% probabilities). SLV(-12%) SIL(-9%) GLD(-8%) GDXJ(-8%) GDX(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.635% (StdDev 3.27%) | Hourly BBV | 0 () | Intraday Trend | 1.7% | | | |
|
1 - 5 Day Possible Target | $-0.19(-102.41%) | Resistance Level | $8.02 | 5 Day Moving Average | $7.67(3%) | 10 Day Moving Average | $7.79(1.41%) | 20 Day Moving Average | $8.02(-1.5%) | To recent high | -18.7% | To recent low | 7% | Market Cap | $1.394b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |